Patent · US Active

Compounds

US10835534B2 · kind B2 · utility

2Cited by
13References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 23, 2019
Grant dateNov 17, 2020
Priority date
Expiry dateDec 23, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D413/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides compounds of formula (I):Said compounds being modulators of Kv3 channels and of use in the prophylaxis or treatment of related disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.